Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
3,051,376
-
Shares change
-
-285,465
-
Total reported value, excl. options
-
$11,045,334
-
Value change
-
-$1,558,767
-
Number of buys
-
15
-
Number of sells
-
-26
-
Price
-
$3.62
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2022
51 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2022.
XBiotech Inc. - Common Shares, no par value (XBIT) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,051,376 shares
of 33,289,095 outstanding shares and own 9.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (854,117 shares), CREDIT SUISSE AG/ (263,708 shares), BlackRock Inc. (258,934 shares), RENAISSANCE TECHNOLOGIES LLC (155,468 shares), GEODE CAPITAL MANAGEMENT, LLC (151,741 shares), MILLENNIUM MANAGEMENT LLC (137,987 shares), Oasis Management Co Ltd. (137,174 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (133,000 shares), MORGAN STANLEY (113,101 shares), and DIMENSIONAL FUND ADVISORS LP (86,273 shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.